Preirradiation chemotherapy with methotrexate, rituximab, and temozolomide and post-irradiation temozolomide for primary central nervous system lymphoma: RTOG 0227 phase II study results.

Jon Glass; Minhee Won; Christopher J. Schultz; Daniel Brat; Nancy Bartlett; John H. Suh; Barbara Jean Fisher; Marcia K. Liepman; Minesh P. Mehta

Preirradiation chemotherapy with methotrexate, rituximab, and temozolomide and post-irradiation temozolomide for primary central nervous system lymphoma: RTOG 0227 phase II study results.

Jon Glass, Minhee Won, Christopher J. Schultz, Daniel Brat, Nancy Bartlett, John H. Suh, Barbara Jean Fisher, Marcia K. Liepman, Minesh P. Mehta

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
State	Published - Jan 30 2017

Disciplines

Pharmacology
Medicine and Health Sciences
Surgery
Immunology and Infectious Disease

Cite this

@article{e353bb19388a4a55924bd0d6dfd89318,

title = "Preirradiation chemotherapy with methotrexate, rituximab, and temozolomide and post-irradiation temozolomide for primary central nervous system lymphoma: RTOG 0227 phase II study results.",

author = "Jon Glass and Minhee Won and Schultz, \{Christopher J.\} and Daniel Brat and Nancy Bartlett and Suh, \{John H.\} and Fisher, \{Barbara Jean\} and Liepman, \{Marcia K.\} and Mehta, \{Minesh P.\}",

year = "2017",

month = jan,

day = "30",

language = "American English",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - Preirradiation chemotherapy with methotrexate, rituximab, and temozolomide and post-irradiation temozolomide for primary central nervous system lymphoma: RTOG 0227 phase II study results.

AU - Glass, Jon

AU - Won, Minhee

AU - Schultz, Christopher J.

AU - Brat, Daniel

AU - Bartlett, Nancy

AU - Suh, John H.

AU - Fisher, Barbara Jean

AU - Liepman, Marcia K.

AU - Mehta, Minesh P.

PY - 2017/1/30

Y1 - 2017/1/30

M3 - Article

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -